Therapeutic modulation of endogenous gene function by agents with designated DNA-sequence specificities

Nucleic Acids Research

Volumn 31, Issue 21, 2003, Pages 6064-6078

  Uil, Taco G ^a,b   Haisma, Hidde J ^b   Rots, Marianne G ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CHOLESTEROL; DESIGNER DRUG; DNA; DNA BINDING PROTEIN; DRUG CARRIER; LIPID; OLIGONUCLEOTIDE; POLYAMIDE; TRANSCRIPTION FACTOR; VIRUS VECTOR; ZINC FINGER PROTEIN;

ANGIOGENESIS; BINDING SITE; DNA BINDING; DNA MODIFICATION; DNA SEQUENCE; DRUG DELIVERY SYSTEM; GENE FUNCTION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING;

ANIMALS; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NYLONS; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0344874246     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg815     Document Type: Review

References (183)

1. Felsenfeld,G., Davies,D.R. and Rich,A. (1957) Formation of a three stranded polynucleotide molecule. J. Am. Chem. Soc., 79, 2023-2024.
2. LeDoan,T., Perrouault,L., Praseuth,D., Habhoub,N., Decout,J.L., Thuong,N.T., Lhomme,J. and Helene,C. (1987) Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[alpha]-thymidylate covalently linked to an azidoproflavine derivative. Nucleic Acids Res., 15, 7749-7760.
3. Moser,H.E. and Dervan,P.B. (1987) Sequence-specific cleavage of double helical DNA by triple helix formation. Science, 238, 645-650.
4. Letai,A.G., Palladino,M.A., Fromm,E., Rizzo,V. and Fresco,J.R. (1988) Specificity in formation of triple-stranded nucleic acid helical complexes: studies with agarose-linked polyribonucleotide affinity columns. Biochemistry, 27, 9108-9112.
5. Faria,M. and Giovannangeli,C. (2001) Triplex-forming molecules: from concepts to applications. J. Gene Med, 3, 299-310.
6. Faria,M. and Ulrich,H. (2002) The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Curr. Cancer Drug Targets, 2, 355-368.
7. Knauert,M.P. and Glazer,P.M. (2001) Triplex forming oligonucleotides: sequence-specific tools for gene targeting. Hum. Mol. Genet., 10, 2243-2251.
8. Vasquez,K.M. and Glazer,P.M. (2002) Triplex-forming oligonucleotides: principles and applications. Q. Rev. Biophys., 35, 89-107.
9. Vasquez,K.M. and Wilson,J.H. (1998) Triplex-directed modification of genes and gene activity. Trends Biochem. Sci., 23, 4-9.
10. Fossella,J.A., Kim,Y.J., Shih,H., Richards,E.G. and Fresco,J.R. (1993) Relative specificities in binding of Watson-Crick base pairs by third strand residues in a DNA pyrimidine triplex motif. Nucleic Acids Res., 21, 4511-4515.
11. Lee,J.S., Johnson,D.A. and Morgan,A.R. (1979) Complexes formed by (pyrimidine)n.(purine)n DNAs on lowering the pH are three-stranded. Nucleic Acids Res., 6, 3073-3091.
12. Hardenbol,P. and Van Dyke,M.W. (1996) Sequence specificity of triplex DNA formation: analysis by a combinatorial approach, restriction endonuclease protection selection and amplification. Proc. Natl Acad. Sci. USA, 93, 2811-2816.
13. Griffin,L.C. and Dervan,P.B. (1989) Recognition of thymine adenine base pairs by guanine in a pyrimidine triple helix motif. Science, 245, 967-971.
14. Wang,E., Malek,S. and Feigon,J. (1992) Structure of a G.T.A triplet in an intramolecular DNA triplex. Biochemistry, 31, 4838-4846.
15. Jiang,L. and Russu,I.M. (2001) Proton exchange and local stability in a DNA triple helix containing a G.TA triad. Nucleic Acids Res., 29, 4231-4237.
16. Arya,D.P. and Bruice,T.C. (1999) Triple-helix formation of DNA oligomers with methylthiourea-linked nucleosides (DNmt): a kinetic and thermodynamic analysis. Proc. Natl Acad Sci. USA, 96, 4384-4389.
17. Escude,C., Giovannangeli,C., Sun,J.S., Lloyd,D.H., Chen,J.K., Gryaznov,S.M., Garestier,T. and Helene,C. (1996) Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation. Proc. Natl Acad Sci. USA, 93, 4365-4369.
18. Dagle,J.M. and Weeks,D.L. (1996) Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation. Nucleic Acids Res., 24, 2143-2149.
19. Ehrenmann,F., Vasseur,J.J. and Debart,F. (2001) Alpha-oligonucleotides with anionic phosphodiester and cationic phosphoramidate linkages enhanced stability of DNA triple helix. Nucl. Nucl., 20, 797-799.
20. Shimizu,M., Konishi,A., Shimada,Y., Inoue,H. and Ohtsuka,E. (1992) Oligo(2′-O-methyl)ribonucleotides. Effective probes for duplex DNA. FEBS Lett., 302, 155-158.
21. Escude,C., Sun,J.S., Rougee,M., Garestier,T. and Helene,C. (1992) Stable triple helices are formed upon binding of RNA oligonucleotides and their 2′-O-methyl derivatives to double-helical DNA. C. R. Acad. Sci. III, 315, 521-525.
22. Torigoe,H., Hari,Y., Sekiguchi,M., Obika,S. and Imanishi,J. (2001) 2′-O,4′-C-methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH: thermodynamic and kinetic studies. J. Biol. Chem., 276, 2354-2360.
23. Lacroix,L., Arimondo,P.B., Takasugi,M., Helene,C. and Mergny,J.L. (2000) Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions. Biochem. Biophys. Res. Commun., 270, 363-369.
24. Blommers,M.J., Natt,F., Jahnke,W. and Cuenoud,B. (1998) Dual recognition of double-stranded DNA by 2′-aminoethoxy-modified oligonucleotides: the solution structure of an intramolecular triplex obtained by NMR spectroscopy. Biochemistry, 37, 17714-17725.
25. Lee,J.S., Woodsworth,M.L., Latimer,L.J. and Morgan,A.R. (1984) Poly(pyrimidine).poly(purine) synthetic DNAs containing 5′-methylcytosine form stable triplexes at neutral pH. Nucleic Acids Res., 12, 6603-6614.
26. Miller,P.S., Bi,G., Kipp,S.A., Fok,V. and DeLong,R.K. (1996) Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine. Nucleic Acids Res., 24, 730-736.
27. Cassidy,S.A., Slickers,P., Trent,J.O., Capaldi,D.C., Roselt,P.D., Reese,C.B., Neidle,S. and Fox,K.R. (1997) Recognition of GC base pairs by triplex forming oligonucleotides containing nucleosides derived from 2-aminopyridine. Nucleic Acids Res., 25, 4891-4898.
28. Escude,C., Giovannangeli,C., Sun,J.S., Lloyd,D.H., Chen,J.K., Gryaznov,S.M., Garestier,T. and Helene,C. (1996) Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation. Proc. Natl Acad. Sci. USA, 93, 4365-4369.
29. Cherny,D.Y., Belotserkovskii,B.P., Frank-Kamenetskii,M.D., Egholm,M., Buchardt,O., Berg,R.H. and Nielsen,P.E. (1993) DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double-stranded DNA. Proc. Natl Acad. Sci. USA, 90, 1667-1670.
30. Nielsen,P.E. (2001) Targeting double stranded DNA with peptide nucleic acid (PNA). Curr. Med. Chem., 8, 545-550.
31. Ray,A. and Norden,B. (2000) Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J., 14, 1041-1060.
32. Durland,R.H., Rao,T.S., Revankar,G.R., Tinsley,J.H., Myrick,M.A., Seth,D.M., Rayford,J., Singh,P. and Jayaraman,K. (1994) Binding of T and T analogs to CG base pairs in antiparallel triplexes. Nucleic Acids Res., 22, 3233-3240.
33. Stilz,H.U. and Dervan,P.B. (1993) Specific recognition of CG base pairs by 2-deoxynebularine within the purine.purine.pyrimidine triple-helix motif. Biochemistry, 32, 2177-2185.
34. Li,J.S., Fan,Y.H., Zhang,Y., Marky,L.A. and Gold,B. (2003) Design of triple helix forming C-glycoside molecules. J. Am. Chem. Soc., 125, 2084-2093.
35. Dervan,P.B. (2001) Molecular recognition of DNA by small molecules. Bioorg. Med. Chem., 9, 2215-2235.
36. Denny,W.A. (2001) DNA minor groove alkylating agents. Curr. Med. Chem., 8, 533-544.
37. Goodsell,D.S. (2001) Sequence recognition of DNA by lexitropsins. Curr. Med. Chem., 8, 509-516.
38. Dervan,P.B. and Edelson,B.S. (2003) Recognition of the DNA minor groove by pyrrole-imidazole polyamides. Curr. Opin. Struct. Biol., 13, 284-299.
39. Lown,J.W. (1988) Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Anticancer Drug Des., 3, 25-40.
40. Reddy,B.S., Sharma,S.K. and Lown,J.W. (2001) Recent developments in sequence selective minor groove DNA effectors. Curr. Med Chem., 8, 475-508.
41. Trauger,J.W., Baird,E.E. and Dervan,P.B. (1996) Recognition of DNA by designed ligands at subnanomolar concentrations. Nature, 382, 559-561.
42. Wemmer,D.E. (2000) Designed sequence-specific minor groove ligands. Annu. Rev. Biophys. Biomol. Struct., 29, 439-461.
43. White,S., Szewczyk,J.W., Turner,J.M., Baird,E.E. and Dervan,P.B. (1998) Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature, 391, 468-471.
44. Kers,I. and Dervan,P.B. (2002) Search for the optimal linker in tandem hairpin polyamides. Bioorg. Med Chem., 10, 3339-3349.
45. Weyermann,P. and Dervan,P.B. (2002) Recognition of ten base pairs of DNA by head-to-head hairpin dimers. J. Am. Chem. Soc., 124, 6872-6878.
46. Choo,Y. and Isalan,M. (2000) Advances in zinc finger engineering. Curr. Opin. Struct. Biol., 10, 411-416.
47. Pabo,C.O., Peisach,E. and Grant,R.A. (2001) Design and selection of novel Cys2His2 zinc finger proteins. Annu. Rev. Biochem., 70, 313-340.
48. Segal,D.J. and Barbas,C.F.,III (2001) Custom DNA-binding proteins come of age: polydactyl zinc-finger proteins. Curr. Opin. Biotechnol., 12, 632-637.
49. Beerli,R.R. and Barbas,C.F.,III (2002) Engineering polydactyl zinc-finger transcription factors. Nat. Biotechnol., 20, 135-141.
50. Isalan,M., Klug,A. and Choo,Y. (2001) A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat. Biotechnol., 19, 656-660.
51. Choo,Y., Sanchez-Garcia,I. and Klug,A. (1994) In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature, 372, 642-645.
52. Wolfe,S.A., Greisman,H.A., Ramm,E.I. and Pabo,C.O. (1999) Analysis of zinc fingers optimized via phage display: evaluating the utility of a recognition code. J. Mol. Biol., 285, 1917-1934.
53. Suzuki,M. and Yagi,N. (1994) DNA recognition code of transcription factors in the helix-turn-helix, probe helix, hormone receptor, and zinc finger families. Proc. Natl Acad. Sci. USA, 91, 12357-12361.
54. Kim,C.A. and Berg,J.M. (1996) A 2.2 Å resolution crystal structure of a designed zinc finger protein bound to DNA. Nature Struct. Biol., 3, 940-945.
55. Sera,T. and Uranga,C. (2002) Rational design of artificial zinc-finger proteins using a nondegenerate recognition code table. Biochemistry, 41, 7074-7081.
56. Choo,Y. and Klug,A. (1994) Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage. Proc. Natl Acad. Sci. USA, 91, 11163-11167.
57. Dreier,B., Segal,D.J. and Barbas,C.F.,III (2000) Insights into the molecular recognition of the 5′-GNN-3′ family of DNA sequences by zinc finger domains. J. Mol. Biol., 303, 489-502.
58. Segal,D.J., Dreier,B., Beerli,R.R. and Barbas,C.F.,III (1999) Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc. Natl Acad. Sci. USA, 96, 2758-2763.
59. Greisman,H.A. and Pabo,C.O. (1997) A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites. Science, 275, 657-661.
60. Cheng,X., Boyer,J.L. and Juliano,R.L. (1997) Selection of peptides that functionally replace a zinc finger in the Sp1 transcription factor by using a yeast combinatorial library. Proc. Natl Acad. Sci. USA, 94, 14120-14125.
61. Bartsevich,V.V. and Juliano,R.L. (2000) Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries. Mol. Pharmacol., 58, 1-10.
62. Dreier,B., Beerli,R.R., Segal,D.J., Flippin,J.D. and Barbas,C.F.,III (2001) Development of zinc finger domains for recognition of the 5′-ANN-3′ family of DNA sequences and their use in the construction of artificial transcription factors. J. Biol. Chem., 276, 29466-29478.
63. Kamiuchi,T., Abe,E., Imanishi,M., Kaji,T., Nagaoka,M. and Sugiura,Y. (1998) Artificial nine zinc-finger peptide with 30 base pair binding sites. Biochemistry, 37, 13827-13834.
64. Kim,J.S. and Pabo,C.O. (1998) Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissociation constants. Proc. Natl Acad. Sci. USA, 95, 2812-2817.
65. Moore,M., Choo,Y. and Klug,A. (2001) Design of polyzinc finger peptides with structured linkers. Proc. Natl Acad. Sci. USA, 98, 1432-1436.
66. Moore,M., Klug,A. and Choo,Y. (2001) Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units. Proc. Natl Acad. Sci. USA, 98, 1437-1441.
67. Pomerantz,J.L., Wolfe,S.A. and Pabo,C.O. (1998) Structure-based deign of a dimeric zinc finger protein. Biochemistry, 37, 965-970.
68. Wang,B.S. and Pabo,C.O. (1999) Dimerization of zinc fingers mediated by peptides evolved in vitro from random sequences. Proc. Natl Acad. Sci. USA, 96, 9568-9573.
69. Wolfe,S.A., Ramm,E.I. and Pabo,C.O. (2000) Combining structure-based design with phage display to create new Cys(2)His(2) zinc finger dimers. Structure Fold. Des., 8, 739-750.
70. Havre,P.A. and Glazer,P.M. (1993) Targeted mutagenesis of simian virus 40 DNA mediated by a triple helix-forming oligonucleotide. J. Virol., 67, 7324-7331.
71. Havre,P.A., Gunther,E.J., Gasparro,F.P. and Glazer,P.M. (1993) Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc. Natl Acad. Sci. USA, 90, 7879-7883.
72. Wang,G., Levy,D.D., Seidman,M.M. and Glazer,P.M. (1995) Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell. Biol., 15, 1759-1768.
73. Majumdar,A., Khorlin,A., Dyatkina,N., Lin,F.L., Powell,J., Liu,J., Fei,Z., Khripine,Y., Watanabe,K.A., George,J. et al. (1998) Targeted gene knockout mediated by triple helix forming oligonucleotides. Nature Genet., 20, 212-214.
74. Vasquez,K.M., Wang,G., Havre,P.A. and Glazer,P.M. (1999) Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells. Nucleic Acids Res., 27, 1176-1181.
75. Vasquez,K.M., Dagle,J.M., Weeks,D.L. and Glazer,P.M. (2001) Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides. J. Biol. Chem., 276, 38536-38541.
76. Barre,F.X., Ait-Si-Ali,S., Giovannangeli,C., Luis,R., Robin,P., Pritchard,L.L., Helene,C. and Harel-Bellan,A. (2000) Unambiguous demonstration of triple-helix-directed gene modification. Proc. Natl Acad. Sci. USA, 97, 3084-3088.
77. Sedelnikova,O.A., Karamychev,V.N., Panyutin,I.G. and Neumann,R.D. (2002) Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Antisense Nucleic Acid Drug Dev., 12, 43-49.
78. Ziemba,A.J., Reed,M.W., Raney,K.D., Byrd,A.B. and Ebbinghaus,S.W. (2003) A bis-alkylating triplex forming oligonucleotide inhibits intracellular reporter gene expression and prevents triplex unwinding due to helicase activity. Biochemistry, 42, 5013-5024.
79. Nagatsugi,F., Sasaki,S., Miller,P.S. and Seidman,M.M. (2003) Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog. Nucleic Acids Res., 31, e31.
80. Arimondo,P.B., Bailly,C., Boutorine,A., Sun,J.S., Garestier,T. and Helene,C. (1999) Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin. C. R. Acad. Sci. III, 322, 785-790.
81. Wang,G., Seidman,M.M. and Glazer,P.M. (1996) Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science, 271, 802-805.
82. Vasquez,K.M., Narayanan,L. and Glazer,P.M. (2000) Specific mutations induced by triplex-forming oligonucleotides in mice. Science, 290, 530-533.
83. Vasquez,K.M., Marburger,K., Intody,Z. and Wilson,J.H. (2001) Manipulating the mammalian genome by homologous recombination. Proc. Natl Acad. Sci. USA, 98, 8403-8410.
84. Brenner,D.A., Smigocki,A.C. and Camerini-Otero,R.D. (1985) Effect of insertions, deletions, and double-strand breaks on homologous recombination in mouse L cells. Mol. Cell. Biol., 5, 684-691.
85. Wake,C.T., Vernaleone,F. and Wilson,J.H. (1985) Topological requirements for homologous recombination among DNA molecules transfected into mammalian cells. Mol., Cell. Biol., 5, 2080-2089.
86. Sargent,R.G., Rolig,R.L., Kilburn,A.E., Adair,G.M., Wilson,J.H. and Nairn,R.S. (1997) Recombination-dependent deletion formation in mammalian cells deficient in the nucleotide excision repair gene ERCC1. Proc. Natl Acad. Sci. USA, 94, 13122-13127.
87. Sandor,Z. and Bredberg,A. (1995) Triple helix directed psoralen adducts induce a low frequency of recombination in an SV40 shuttle vector. Biochim. Biophys. Acta, 1263, 235-240.
88. Faruqi,A.F., Seidman,M.M., Segal,D.J., Carroll,D. and Glazer,P.M. (1996) Recombination induced by triple-helix-targeted DNA damage in mammalian cells. Mol. Cell. Biol., 16, 6820-6828.
89. Luo,Z., Macris,M.A., Faruqi,A.F. and Glazer,P.M. (2000) High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc. Natl Acad. Sci. USA, 97, 9003-9008.
90. Chan,P.P., Lin,M., Faruqi,A.F., Powell,J., Seidman,M.M. and Glazer,P.M. (1999) Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J. Biol. Chem., 274, 11541-11548.
91. Faruqi,A.F., Datta,H.J., Carroll,D., Seidman,M.M. and Glazer,P.M. (2000) Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol. Cell. Biol., 20, 990-1000.
92. Datta,H.J., Chan,P.P., Vasquez,K.M., Gupta,R.C. and Glazer,P.M. (2001) Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J. Biol. Chem., 276, 18018-18023.
93. Datta,H.J. and Glazer,P.M. (2001) Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination. Nucleic Acids Res., 29, 5140-5147.
94. Wang,Y.D., Dziegielewski,J., Wurtz,N.R., Dziegielewska,B., Dervan,P.B. and Beerman,T.A. (2003) DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate. Nucleic Acids Res., 31, 1208-1215.
95. Wang,Y.D., Dziegielewski,J., Chang,A.Y., Dervan,P.B. and Beerman,T.A. (2002) Cell-free and cellular activities of a DNA sequence selective hairpin polyamide-CBI conjugate. J. Biol. Chem., 277, 42431-42437.
96. Bando,T., Narita,A., Saito,I. and Sugiyama,H. (2002) Molecular design of a pyrrole-imidazole hairpin polyamides for effective DNA alkylation. Chemistry, 8, 4781-4790.
97. Kim,Y.G., Cha,J. and Chandrasegaran,S. (1996) Hybrid restriction enzymes:. zinc finger fusions to Fok I cleavage domain. Proc. Natl Acad. Sci. USA, 93, 1156-1160.
98. Huang,B., Schaeffer,C.J., Li,Q. and Tsai,M.D. (1996) Splase: a new class IIS zinc-finger restriction endonuclease with specificity for Sp1 binding sites. J. Protein Chem., 15, 481-489.
99. Smith,J., Berg,J.M. and Chandrasegaran,S. (1999) A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res., 27, 674-681.
100. Smith,J., Bibikova,M., Whitby,F.G., Reddy,A.R., Chandrasegaran,S. and Carroll,D. (2000) Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res., 28, 3361-3369.
101. Bibikova,M., Carroll,D., Segal,D.J., TrautmanJ.K., Smith,J., Kim,Y.G. and Chandrasegaran,S. (2001) Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell. Biol. 21, 289-297.
102. Bibikova,M., Beumer,K., Trautman,J.K. and Carroll,D. (2003) Enhancing gene targeting with designed zinc finger nucleases. Science, 300, 764.
103. Bibikova,M., Golic,M., Golic,K.G. and Carroll,D. (2002) Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics, 161, 1169-1175.
104. Porteus,M.H. and Baltimore,D. (2003) Chimeric nucleases stimulate gene targeting in human cells. Science, 300, 763.
105. Chandrasegaran,S. and Smith,J. (1999) Chimeric restriction enzymes: what is next? Biol. Chem., 380, 841-848.
106. Cooney,M., Czernuszewicz,G., Postel,E.H., Flint,S.J. and Hogan,M.E. (1988) Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science, 241, 456-459.
107. Grigoriev,M., Praseuth,D., Robin,P., Hemar,A., Saison-Behmoaras,T., Dautry-Varsat,A., Thuong,N.T., Helene,C. and Harel-Bellan,A. (1992) A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence. J. Biol. Chem., 267, 3389-3395.
108. Mayfield,C., Ebbinghaus,S., Gee,J., Jones,D., Rodu,B., Squibb,M. and Miller,D. (1994) Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription. J. Biol. Chem., 269, 18232-18238.
109. Duval-Valentin,G., Thuong,N.T. and Helene,C. (1992) Specific inhibition of transcription by triple helix-forming oligonucleotides. Proc. Natl Acad. Sci. USA, 89, 504-508.
110. Kim,H.G. and Miller,D.M. (1995) Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter. Biochemistry, 34, 8165-8171.
111. Joseph,J., Kandala,J.C., Veerapanane,D., Weber,K.T. and Guntaka,R.V. (1997) Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Nucleic Acids Res., 25, 2182-2188.
112. Ritchie,S., Boyd,F.M., Wong,J. and Bonham,K. (2000) Transcription of the human c-Src: promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides. J. Biol. Chem., 275, 847-854.
113. Postel,E.H., Flint,S.J., Kessler,D.J. and Hogan,M.E. (1991) Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc. Natl Acad. Sci. USA, 88, 8227-8231.
114. Thomas,T.J., Faaland,C.A., Gallo,M.A. and Thomas,T. (1995) Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells. Nucleic Acids Res., 23, 3594-3599.
115. Orson,F.M., Thomas,D.W., McShan,W.M., Kessler,D.J. and Hogan,M.E. (1991) Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res., 19, 3435-3441.
116. Tu,G.C., Cao,Q.N. and Israel,Y. (1995) Inhibition of gene expression by triple helix formation in hepatoma cells. J. Biol. Chem., 270, 28402-28407.
117. Kochetkova,M. and Shannon,M.F. (1996) DNA triplex formation selectively inhibits granulocyte-macrophage colony-stimulating factor gene expression in human T cells. J. Biol. Chem., 271, 14438-14444.
118. Porumb,H., Gousset,H., Letellier,R., Salle,V., Briane,D., Vassy,J., Amor-Gueret,M., Israel,L. and Taillandier,E. (1996) Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide. Cancer Res., 56, 515-522.
119. Marchand,P., Resch,K. and Radeke,H.H. (2000) Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides. J. Immunol., 164, 2070-2076.
120. Carbone,G.M., McGuffie,E.M., Collier,A. and Catapano,C.V. (2003) Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide. Nucleic Acids Res., 31, 833-843.
121. Neurath,M.F., Max,E.E. and Strober,W. (1995) Pax5 (BSAP) regulates the murine immunoglobulin 3′ alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc. Natl Acad. Sci. USA, 92, 5336-5340.
122. Musso,M., Wang,J.C. and Van Dyke,M.W. (1996) In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides. Nucleic Acids Res., 24, 4924-4932.
123. Bonham,M.A., Brown,S., Boyd,A.L., Brown,P.H., Bruckenstein,D.A., Hanvey,J.C., Thomson,S.A., Pipe,A., Hassman,F., Bisi,J.E. et al. (1995) An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res., 23, 1197-1203.
124. Degols,G., Clarenc,J.P., Lebleu,B. and Leonetti,J.P. (1994) Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells. J. Biol. Chem., 269, 16933-16937.
125. Shevelev,A., Burfeind,P., Schulze,E., Rininsland,F., Johnson,T.R., Trojan,J., Chernicky,C.L., Helene,C., Ilan,J. and Ilan,J. (1997) Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model. Cancer Gene Ther., 4, 105-112.
126. Rininsland,F., Johnson,T.R., Chernicky,C.L., Schulze,E., Burfeind,P. and Ilan,J. (1997) Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl Acad. Sci. USA, 94, 5854-5859.
127. Aggarwal,B.B., Schwarz,L., Hogan,M.E. and Rando,R.F. (1996) Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res., 56, 5156-5164.
128. Giovannangeli,C., Perrouault,L., Escude,C., Gryaznov,S. and Helene,C. (1996) Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA. J. Mol. Biol., 261, 386-398.
129. Faria,M., Wood,C.D., Perrouault,L., Nelson,J.S., Winter,A. White,M.R., Helene,C. and Giovannangeli,C. (2000) Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc. Natl Acad. Sci. USA, 97, 3862-3867.
130. Faria,M., Wood,C.D., White,M.R., Helene,C. and Giovannangeli,C. (2001) Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells. J. Mol. Biol., 306, 15-24.
131. Besch,R., Giovannangeli,C., Kammerbauer,C. and Degitz,K. (2002) Specific inhibition of ICAM-1 expression mediated by gene targeting with triplex-forming oligonucleotides. J. Biol. Chem., 277, 32473-32479.
132. Shen,C., Buck,A., Polat,B., Schmid-Kotsas,A., Matuschek,C., Gross,H.J., Bachem,M. and Reske,S.N. (2003) Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther., 10, 403-410.
133. Kuznetsova,S., Ait-Si-Ali,S., Nagibneva,I., Troalen,F., Le Villain,J.P., Harel-Bellan,A. and Svinarchuk,F. (1999) Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16. Nucleic Acids Res., 27, 3995-4000.
134. Mollegaard,N.E., Buchardt,O., Egholm,M. and Nielsen,P.E. (1994) Peptide nucleic acid.DNA strand displacement loops as artificial transcription promoters. Proc. Natl Acad. Sci. USA, 91, 3892-3895.
135. Wang,G., Xu,X., Pace,B., Dean,D.A., Glazer,P.M., Chan,P., Goodman,S.R. and Shokolenko,I. (1999) Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression. Nucleic Acids Res., 27, 2806-2813.
136. Gottesfeld,J.M., Neely,L., Trauger,J.W., Baird,E.E. and Dervan,P.B. (1997) Regulation of gene expression by small molecules. Nature, 387, 202-205.
137. Dickinson,L.A., Gulizia,R.J., Trauger,J.W., Baird,E.E., Mosier,D.E., Gottesfeld,J.M. and Dervan,P.B. (1998) Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc. Natl Acad. Sci. USA, 95, 12890-12895.
138. Schaal,T.D., Mallet,W.G., McMinn,D.L., Nguyen,N.V., Sopko,M.M., John,S. and Parekh,B.S. (2003) Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides. Nucleic Acids Res., 31, 1282-1291.
139. Coull,J.J., He,G., Melander,C., Rucker,V.C., Dervan,P.B. and Margolis,D.M. (2002) Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrroleimidazole polyamides. J. Virol., 76, 12349-12354.
140. Mapp,A.K., Ansari,A.Z., Ptashne,M. and Dervan,P.B. (2000) Activation of gene expression by small molecule transcription factors. Proc. Natl Acad. Sci. USA, 97, 3930-3935.
141. Ansari,A.Z., Mapp,A.K., Nguyen,D.H., Dervan,P.B. and Ptashne,M. (2001) Towards a minimal motif for artificial transcriptional activators. Chem. Biol., 8, 583-592.
142. Arora,P.S., Ansari,A.Z., Best,T.P., Ptashne,M. and Dervan,P.B. (2002) Design of artificial transcriptional activators with rigid poly-L-proline linkers. J. Am. Chem. Soc., 124, 13067-13071.
143. Chiang,S.Y., Burli,R.W., Benz,C.C., Gawron,L., Scott,G.K., Dervan,P.B. and Beerman,T.A. (2000) Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. J. Biol. Chem., 275, 24246-24254.
144. Belitsky,J.M., Leslie,S.J., Arora,P.S., Beerman,T.A. and Dervan,P.B. (2002) Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorg. Med. Chem., 10, 3313-3318.
145. Janssen,S., Cuvier,O., Muller,M. and Laemmli,U.K. (2000) Specific gain- and loss-of-function phenotypes induced by satellite-specific DNA-binding drugs fed to Drosophila melanogaster. Mol. Cell, 6, 1013-1024.
146. Kang,J.S. and Kim,J.S. (2000) Zinc finger proteins as designer transcription factors. J. Biol. Chem., 275, 8742-8748.
147. Beerli,R.R., Segal,D.J., Dreier,B. and Barbas,C.F.,III (1998) Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl Acad. Sci. USA, 95, 14628-14633.
148. Kim,J.S. and Pabo,C.O. (1997) Transcriptional repression by zinc finger peptides. Exploring the potential for applications in gene therapy. J. Biol. Chem., 272, 29795-29800.
149. Kim,J.S., Kim,J., Cepek,K.L., Sharp,P.A. and Pabo,C.O. (1997) Design of TATA box-binding protein/zinc finger fusions for targeted regulation of gene expression. Proc. Natl Acad. Sci. USA, 94, 3616-3620.
150. Sadowski,I., Ma,J., Triezenberg,S. and Ptashne,M. (1988) GAL4-VP16 is an unusually potent transcriptional activator. Nature, 335, 563-564.
151. Fujita,T., Nolan,G.P., Ghosh,S. and Baltimore,D. (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev., 6, 775-787.
152. Margolin,J.F., Friedman,J.R., Meyer,W.K., Vissing,H., Thiesen,H.J. and Rauscher,F.J.,III (1994) Kruppel-associated boxes are potent transcriptional repression domains. Proc. Natl Acad. Sci. USA, 91, 4509-4513.
153. Heinzel,T., Lavinsky,R.M., Mullen,T.M., Soderstrom,M., Laherty,C.D., Torchia,J., Yang,W.M., Brard,G., Ngo,S.D., Davie,J.R. et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature, 387, 43-48.
154. Damm,K., Thompson,C.C. and Evans,R.M. (1989) Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature, 339, 593-597.
155. Beerli,R.R., Dreier,B. and Barbas,C.F.,III (2000) Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl Acad. Sci. USA, 97, 1495-1500.
156. Zhang,L., Spratt,S.K., Liu,Q., Johnstone,B., Qi,H., Raschke,E.E., Jamieson,A.C., Rebar,E.J., Wolffe,A.P. and Case,C.C. (2000) Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene. J. Biol. Chem., 275, 33850-38660.
157. Liu,P.Q., Rebar,E.J., Zhang,L., Liu,Q., Jamieson,A.C., Liang,Y., Qi,H., Li,P.X., Chen,B., Mendel,M.C. et al. (2001) Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J. Biol. Chem., 276, 11323-11334.
158. Ren,D., Collingwood,T.N., Rebar,E.J., Wolffe,A.P. and Camp,H.S. (2002) PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev., 16, 27-32.
159. Falke,D., Fisher,M., Ye,D. and Juliano,R.L. (2003) Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene. Nucleic Acids Res., 31, e10.
160. Jouvenot,Y., Ginjala,V., Zhang,L., Liu,P.Q., Oshimura,M., Feinberg,A.P., Wolffe,A.P., Ohlsson,R. and Gregory,P.D. (2003) Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors. Gene Ther., 10, 513-522.
161. Rebar,E.J., Huang,Y., Hickey,R., Nath,A.K., Meoli,D., Nath,S., Chen,B., Xu,L., Liang,Y., Jamieson,A.C. et al. (2002) Induction of angiogenesis in a mouse model using engineered transcription factors. Nat. Med., 8, 1427-1432.
162. Hobbs,C.A. and Yoon,K. (1994) Differential regulation of gene expression in vivo by triple helix-forming oligonucleotides as detected by a reporter enzyme. Antisense Res. Dev., 4, 1-8.
163. Boussif,O., Lezoualc'h,F., Zanta,M.A., Mergny,M.D., Scherman,D., Demeneix,B. and Behr,J.P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA, 92, 7297-7301.
164. Macaulay,V.M., Bates,P.J., McLean,M.J., Rowlands,M.G., Jenkins,T.C., Ashworth,A. and Neidle,S. (1995) Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence. FEBS Lett., 372, 222-228.
165. Vlassov,V.V., Balakireva,L.A. and Yakubov,L.A. (1994) Transport of oligonucleotides across natural and model membranes. Biochim. Biophys. Acta, 1197, 95-108.
166. Noonberg,S.B., Scott,G.K., Garovoy,M.R., Benz,C.C. and Hunt,C.A. (1994) In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation. Nucleic Acids Res., 22, 2830-2836.
167. Chen,Y., Ji,Y.J., Roxby,R. and Conrad,C. (2000) In vivo expression of single-stranded DNA in mammalian cells with DNA enzyme
168. Ragin,A., Morgan,R. and Chmielewski,J. (2002) Cellular import mediated by nuclear localization signal Peptide sequences. Chem. Biol., 9, 943.
169. Rout,M.P. and Aitchison,J.D. (2001) The nuclear pore complex as a transport machine. J. Biol. Chem., 276, 16593-16596.
170. Crowley,K.S., Phillion,D.P., Woodard,S.S., Schweitzer,B.A., Singh,M., Shabany,H., Burnette,B., Hippenmeyer,P., Heitmeier,M. and Bashkin,J.K. (2003) Controlling the intracellular localization of fluorescent polyamide analogues in cultured cells. Bioorg. Med Chem. Lett., 13, 1565-1570.
171. Briehn,C.A., Weyermann,P. and Dervan,P.B. (2003) Alternative heterocycles for DNA recognition: the benzimidazole/imidazole pair. Chemistry, 9, 2110-2122.
172. Renneberg,D. and Dervan,P.B. (2003) Imidazopyridine/pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognition. J. Am. Chem. Soc., 125, 5707-5716.
173. Macris,M.A. and Glazer,P.M. (2003) Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides. J. Biol. Chem., 278, 3357-3362.
174. Majumdar,A., Puri,N., Cuenoud,B., Natt,F., Martin,P., Khorlin,A., Dyatkina,N., George,A.J., Miller,P.S. and Seidman,M.M. (2003) Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide. J. Biol. Chem., 278, 11072-11077.
175. Gottesfeld,J.M., Melander,C., Suto,R.K., Raviol,H., Luger,K. and Dervan,P.B. (2001) Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. J. Mol. Biol., 309, 615-629.
176. Gottesfeld,J.M., Belitsky,J.M., Melander,C., Dervan,P.B. and Luger,K. (2002) Blocking transcription through a nucleosome with synthetic DNA ligands. J. Mol. Biol., 321, 249-263.
177. Suto,R.K., Edayathumangalam,R.S., White,C.L., Melander,C., Gottesfeld,J.M., Dervan,P.B. and Luger,K. (2003) Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands. J. Mol. Biol., 326, 371-380.
178. Bae,K.H., Do,K.Y., Shin,H.C., Hwang,M.S., Ryu,E.H., Park,K.S., Yang,H.Y., Lee,D.K., Lee,Y., Park,J. et al. (2003) Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat. Biotechnol., 21, 275-280.
179. Blancafort,P., Magnenat,L. and Barbas,C.F. (2003) Scanning the human genome with combinatorial transcription factor libraries. Nat. Biotechnol., 21, 269-274.
180. Clackson,T. (2000) Regulated gene expression systems. Gene Ther., 7, 120-125.
181. Auricchio,A., Rivera,V., Clackson,T., O'Connor,E., Maguire,A., Tolentino,M., Bennett,J. and Wilson,J. (2002) Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther., 6, 238.
182. Beerli,R.R., Schopfer,U., Dreier,B. and Barbas,C.F.,III (2000) Chemically regulated zinc finger transcription factors. J. Biol. Chem., 275, 32617-32627.
183. Pollock,R., Giel,M., Linher,K. and Clackson,T. (2002) Regulation of endogenous gene expression with a small-molecule dimerizer. Nat. Biotechnol., 20, 729-733.